-
2
-
-
84871928479
-
Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients
-
Bellmunt J 2013 Tackling the bone with alpha emitters in metastatic castration-resistant prostate cancer patients Eur. Urology 63 pp 198-200
-
(2013)
Eur. Urology
, vol.63
, pp. 198-200
-
-
Bellmunt, J.1
-
3
-
-
35549000927
-
Targeted α -therapy: Past, present, future?
-
Brechbiel M 2007 Targeted α -therapy: past, present, future? J. R. Soc. Chem. 43 4918-28
-
(2007)
J. R. Soc. Chem.
, vol.43
, pp. 4918-4928
-
-
Brechbiel, M.1
-
4
-
-
84880951139
-
Radiation damage on sub-cellular scales: Beyond DNA
-
Byrne H, McNamara A, Domanova W, Guatelli S and Kuncic Z 2013 Radiation damage on sub-cellular scales: beyond DNA Phys. Med. Biol. 58 pp 1251-67
-
(2013)
Phys. Med. Biol.
, vol.58
, Issue.5
, pp. 1251-1267
-
-
Byrne, H.1
McNamara, A.2
Domanova, W.3
Guatelli, S.4
Kuncic, Z.5
-
5
-
-
23844506164
-
Geant4 low energy electromagnetic physics
-
Chauvie S et al 2004 Geant4 low energy electromagnetic physics IEEE Nucl. Sci. Conf. R. 3 1881-5
-
(2004)
IEEE Nucl. Sci. Conf. R.
, vol.3
, pp. 1881-1885
-
-
Chauvie, S.1
-
6
-
-
23844506164
-
Geant4 low energy electromagnetic physics
-
Chauvie S et al 2004 Geant4 low energy electromagnetic physics IEEE Nucl. Sci. Conf. R. 3 16-22
-
(2004)
IEEE Nucl. Sci. Conf. R.
, vol.3
, pp. 16-22
-
-
Chauvie, S.1
-
7
-
-
84860150328
-
Alpha particles as radiopharmaceuticals in the treatment of bone metastases: Mechanism of action of radium-223 chloride (Alpharadin) and radiation
-
Cheetham P and Petrylak D 2012 Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation J. Oncol. 26 330-7
-
(2012)
J. Oncol.
, vol.26
, pp. 330-337
-
-
Cheetham, P.1
Petrylak, D.2
-
8
-
-
84873691909
-
Radium-223 for the treatment of prostate cancer
-
Hafeez S and Parker C 2013 Radium-223 for the treatment of prostate cancer Expert. Opin. Investig. Drugs 22 379-87
-
(2013)
Expert. Opin. Investig. Drugs
, vol.22
, pp. 379-387
-
-
Hafeez, S.1
Parker, C.2
-
9
-
-
84860677986
-
A bone marrow toxicity model for 223Ra alpha-emitter radiopharmaceutical therapy
-
Hobbs R, Song H, Watchman C, Bolch W, Aksnes A, Ramdahl T, Flux G and Sgouros G 2012 A bone marrow toxicity model for 223Ra alpha-emitter radiopharmaceutical therapy Phys. Med. Biol. 57 3207
-
(2012)
Phys. Med. Biol.
, vol.57
, Issue.10
, pp. 3207
-
-
Hobbs, R.1
Song, H.2
Watchman, C.3
Bolch, W.4
Aksnes, A.5
Ramdahl, T.6
Flux, G.7
Sgouros, G.8
-
10
-
-
5744251917
-
GATE: A simulation toolkit for PET and SPECT
-
Jan S et al 2004 GATE: a simulation toolkit for PET and SPECT Phys. Med. Biol. 49 4543
-
(2004)
Phys. Med. Biol.
, vol.49
, Issue.19
, pp. 4543
-
-
Jan, S.1
-
11
-
-
84924770716
-
Advances in computational radiation biophysics for cancer therapy: Simulating nano-scale damage by low-energy electrons
-
Kuncic Z 2014 Advances in computational radiation biophysics for cancer therapy: simulating nano-scale damage by low-energy electrons Biophys. Rev. Lett. 10 1-12
-
(2014)
Biophys. Rev. Lett.
, vol.10
, pp. 1-12
-
-
Kuncic, Z.1
-
12
-
-
84874106208
-
Dosimetry of 223Ra-chloride: Dose to normal organs and tissues
-
Lassmann M and Nosske D 2013 Dosimetry of 223Ra-chloride: dose to normal organs and tissues Eur. J. Nucl. Med. Mol. Imaging 40 207-12
-
(2013)
Eur. J. Nucl. Med. Mol. Imaging
, vol.40
, pp. 207-212
-
-
Lassmann, M.1
Nosske, D.2
-
13
-
-
71249088083
-
Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer
-
Liepe K 2009 Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer Curr. Opin. Investig. Drugs 10 1346-58
-
(2009)
Curr. Opin. Investig. Drugs
, vol.10
, pp. 1346-1358
-
-
Liepe, K.1
-
14
-
-
0031715792
-
Radioimmunotherapy with alpha-emitting nuclides
-
McDevitt M, Sgouros G, Finn R, Humm J, Jurcic J, Larson S and Scheinberg D 1998 Radioimmunotherapy with alpha-emitting nuclides Eur. J. Nucl. Med. Mol. Imaging 25 1341-51
-
(1998)
Eur. J. Nucl. Med. Mol. Imaging
, vol.25
, pp. 1341-1351
-
-
McDevitt, M.1
Sgouros, G.2
Finn, R.3
Humm, J.4
Jurcic, J.5
Larson, S.6
Scheinberg, D.7
-
15
-
-
84856406453
-
Overall survival benefit of radium-223 chloride (Alpharadin) in the treatment of patients with symptomatic bone metastases in castration-resistant prostate cancer (CRPC): A phase III randomized trial (ALSYMPCA)
-
Parker C et al 2011 Overall survival benefit of radium-223 chloride (Alpharadin) in the treatment of patients with symptomatic bone metastases in castration-resistant prostate cancer (CRPC): a phase III randomized trial (ALSYMPCA) Eur. J. Cancer 47 3
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 3
-
-
Parker, C.1
-
16
-
-
84880428467
-
Alpha emitter radium-223 and survival in metastatic prostate cancer
-
Parker C et al 2013 Alpha emitter radium-223 and survival in metastatic prostate cancer New Engl. Econ. Rev. 369 213-23
-
(2013)
New Engl. Econ. Rev.
, vol.369
, pp. 213-223
-
-
Parker, C.1
-
17
-
-
84938144953
-
Alpha particles as radiopharmaceuticals in the treatment of bone metastases: Mechanism of action of radium-223 chloride (Alpharadin) and radiation
-
Philippa J C and Daniel P P 2012 Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation Oncol. J. 330-7 341
-
(2012)
Oncol. J.
, vol.330
, Issue.7
, pp. 341
-
-
Philippa, J.C.1
Daniel, P.P.2
-
18
-
-
64649084383
-
Radiation-induced bystander signalling in cancer therapy
-
Prise K and O'Sullivan J 2009 Radiation-induced bystander signalling in cancer therapy Nat. Rev. Cancer 9 351-60
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 351-360
-
-
Prise, K.1
O'Sullivan, J.2
-
19
-
-
34247497372
-
Alpha-particle Monte Carlo simulation for microdosimetric calculations using a commercial spreadsheet
-
Roeske J and Hoggarth M 2007 Alpha-particle Monte Carlo simulation for microdosimetric calculations using a commercial spreadsheet Phys. Med. Biol. 52 1909
-
(2007)
Phys. Med. Biol.
, vol.52
, Issue.7
, pp. 1909
-
-
Roeske, J.1
Hoggarth, M.2
-
20
-
-
33646003218
-
The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population
-
Roeske J and Stinchcomb T 2006 The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population Phys. Med. Biol. 51 179
-
(2006)
Phys. Med. Biol.
, vol.51
, pp. 179
-
-
Roeske, J.1
Stinchcomb, T.2
-
21
-
-
84869081194
-
Targeted radio-nuclide therapy of skeletal metastases
-
Sartor O, Hoskin P and Brul 2013 Targeted radio-nuclide therapy of skeletal metastases Cancer Treat. Rev. 39 18-26
-
(2013)
Cancer Treat. Rev.
, vol.39
, pp. 18-26
-
-
Sartor, O.1
Hoskin, P.2
Brul3
-
22
-
-
46949111791
-
Alpha-particles for targeted therapy
-
Sgouros G 2008 Alpha-particles for targeted therapy Adv. Drug Deliv. Rev. 60 1402-6
-
(2008)
Adv. Drug Deliv. Rev.
, vol.60
, pp. 1402-1406
-
-
Sgouros, G.1
|